UroGen Pharma Ltd (URGN)
13.82
-0.39
(-2.74%)
USD |
NASDAQ |
Apr 25, 16:00
13.85
+0.03
(+0.22%)
After-Hours: 20:00
UroGen Pharma Market Cap: 471.57M for April 25, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| April 25, 2024 | 471.57M |
| April 24, 2024 | 484.88M |
| April 23, 2024 | 495.79M |
| April 22, 2024 | 490.33M |
| April 19, 2024 | 468.50M |
| April 18, 2024 | 486.58M |
| April 17, 2024 | 485.90M |
| April 16, 2024 | 494.43M |
| April 15, 2024 | 515.24M |
| April 12, 2024 | 515.24M |
| April 11, 2024 | 452.12M |
| April 10, 2024 | 441.88M |
| April 09, 2024 | 456.21M |
| April 08, 2024 | 450.75M |
| April 05, 2024 | 464.06M |
| April 04, 2024 | 465.43M |
| April 03, 2024 | 466.11M |
| April 02, 2024 | 480.78M |
| April 01, 2024 | 484.53M |
| March 28, 2024 | 511.83M |
| March 27, 2024 | 510.47M |
| March 26, 2024 | 517.63M |
| March 25, 2024 | 568.47M |
| March 22, 2024 | 537.76M |
| March 21, 2024 | 509.78M |
| Date | Value |
|---|---|
| March 20, 2024 | 510.47M |
| March 19, 2024 | 512.51M |
| March 18, 2024 | 494.77M |
| March 15, 2024 | 493.41M |
| March 14, 2024 | 488.97M |
| March 13, 2024 | 596.11M |
| March 12, 2024 | 601.23M |
| March 11, 2024 | 583.49M |
| March 08, 2024 | 613.86M |
| March 07, 2024 | 615.22M |
| March 06, 2024 | 586.45M |
| March 05, 2024 | 585.15M |
| March 04, 2024 | 598.47M |
| March 01, 2024 | 577.35M |
| February 29, 2024 | 595.54M |
| February 28, 2024 | 590.35M |
| February 27, 2024 | 603.99M |
| February 26, 2024 | 583.52M |
| February 23, 2024 | 555.26M |
| February 22, 2024 | 578.00M |
| February 21, 2024 | 574.75M |
| February 20, 2024 | 625.11M |
| February 16, 2024 | 628.03M |
| February 15, 2024 | 610.81M |
| February 14, 2024 | 624.46M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
116.19M
Minimum
May 25 2022
818.14M
Maximum
May 21 2019
408.34M
Average
414.23M
Median
Dec 06 2023
Market Cap Benchmarks
| Agenus Inc | 173.85M |
| Exelixis Inc | 7.134B |
| Geron Corp | 1.944B |
| Protalix BioTherapeutics Inc | 86.20M |
| InfuSystems Holdings Inc | 161.82M |
Market Cap Related Metrics
| PS Ratio | 4.816 |
| Price | 13.82 |
| Earnings Yield | -26.56% |